Telix Pharmaceuticals | TLX - Sales Revenues

Stock Price
15.00
Daily Change
0 0%
Monthly
9.81%
Yearly
-46.41%
Q2 Forecast
14.62

Telix Pharmaceuticals reported AUD413.44M in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Cochlear AUD 1.18B 590.35M Dec/2025
CSL USD 8.33B 4.79B Dec/2025
Integral Diagnostics AUD 238.44M 7.19M Jun/2024
Mayne Pharma AUD 212.07M 17.03M Dec/2025
Medical Developments International AUD 21.57M 12.04M Dec/2025
Mesoblast USD 30.3M 17.1M Dec/2025
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Pacific Edge NZD 5.94M 4.95M Dec/2025
Paradigm Biopharmaceuticals AUD 284.06K 292.06K Dec/2025
Polynovo AUD 70.33M 35.75M Dec/2025
PYC Therapeutics AUD 11.04M 2.44M Dec/2025
Ramsay Health Care AUD 9.34B 82.2M Dec/2025
ResMed USD 1.42B 87.23M Dec/2025
Sonic Healthcare AUD 5.45B 470M Dec/2025